期刊文献+

大肠癌组织p53、PCNA的定量检测与临床病理及预后的关系 被引量:2

Quantitative Study on p53 and PCNA in Colorectal Cancer and its Clinopathological Correlection and Prognostic Significance
暂未订购
导出
摘要 目的 :探讨p5 3蛋白、增殖细胞核抗原 (PCNA)在结直肠癌细胞中的表达情况与临床病理及预后的关系。方法 :应用自动化图像分析技术及SP法免疫组化 ,对 5 3例大肠癌、30例大肠腺瘤及 10例正常肠黏膜进行p5 3、PCNA的定量检测。结果 :p5 3、PCNA阳性率分别为 5 2 38%、97 73%。上述指标各参数值在正常肠黏膜→腺瘤→腺癌的顺序呈递变趋势 ,伴有淋巴结转移的腺癌组中 ,上述各参数值明显增高。p5 3与PCNA呈正相关 ,与组织分化程度无关。结论 :定量检测p5 3、PCNA对判断大肠癌的恶性程度。 Objective To evaluate expression of p53 and PCNA in colorectal tumor and its clinopathological correlection andprognostic significance.Methods 10 normal colonic mucosae,30 colorectal adenomas and 53 colorectal carcinomas with complete follow up data were examined for PCNA and p53 with quantitative computed processed imaging analysis and SP immunohistochemical technique.Results p53 and PCNA positive rate were 52 38%,97 73%.The values of the parameters analyzed increased in accordance with the normal mucosa adenoma adenocarcinoma sequence,and were higher in patient with lymph node metastasis evidently p53 positive tumors always coexisted with over expression of PCNA.There was no significant correlation between p53 expression and differentiated degree of cancer.Conclusions p53 and PCNA may be useful in evaluating malignancy degree and prognosis.The quantitative evaluation of some indices of colorectal tumor can provide reproducible data for differential diagnosis of this tumor.
出处 《肿瘤防治杂志》 CAS 2001年第6期613-615,共3页 China Journal of Cancer Prevention and Treatment
基金 福建省教委科研基金资助 ( 97A0 6 8)
关键词 结直肠肿瘤 病理学 蛋白质P53 核蛋白类 免疫组织化学 图像处理 计算机辅助 预后 colorectal neoplasms/pathology protein p53 uncleoproteins immunohistochemistry imaging processing computer assisted prognosis
  • 相关文献

参考文献4

二级参考文献1

  • 1甘华田,中华消化杂志,1996年,16卷,36页

共引文献105

同被引文献10

  • 1甘华田,欧阳钦,王一平,李甘地,马洪升,陈岱云,李奉媛.大肠癌p53蛋白表达与细胞增殖状态及预后的关系[J].中华肿瘤杂志,1996,18(4):244-246. 被引量:15
  • 2Deveraux QL,Takahashi R, Salvesen GS, et al. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388(6639) :300-304.
  • 3Ambrosini G,Adida C, Altieri DC. A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma. Nat Med, 1997,3(8) :917-921.
  • 4Lo Muzio L, Staibano S, Pannone G, et al. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol,2001,70(3):249-254.
  • 5Monzo M,Rosell R,Felip E,et al. A novel anti-apoptosis gene;Re expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol, 1999, 17(7):2100-2104.
  • 6Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res, 1998,58(9) : 1808-1812.
  • 7Adida C, Haioun C,Gaulard P, et al. Prognostic significance of survivln expression in diffuse large B-celllymphomas. Blood,2000,96(5) : 1921-1925.
  • 8Recher C,Raffoux E. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol,2000,111(1) :196-203.
  • 9Sarela AI, Macadam RC, Farmery SM, et al. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma Gut,2000,46(5):645-650.
  • 10钟雪云.肺和胸膜肿瘤的病理组织学新分类[J].中国肿瘤,2000,9(3):129-130. 被引量:14

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部